Table III.
The association between lncRNA MIAT expression and clinicopathological variables of patients with gastric cancer.
| lncRNA MIAT expression | ||||
|---|---|---|---|---|
| Variables | Value (n) | High (n=23) | Low (n=24) | P-value |
| Sex | 0.1351 | |||
| Male | 30 | 18 | 12 | |
| Female | 17 | 5 | 12 | |
| Age, years | 0.2124 | |||
| ≤60 | 15 | 5 | 10 | |
| >60 | 32 | 18 | 14 | |
| Tumor size, cm | 0.3852 | |||
| ≤5 | 22 | 9 | 13 | |
| >5 | 25 | 14 | 11 | |
| Depth of invasion | 0.1468 | |||
| T1+T2 | 22 | 8 | 14 | |
| T3+T4 | 25 | 15 | 10 | |
| Differentiation | ||||
| Well or moderate | 21 | 8 | 13 | 0.2443 |
| Poor or other | 26 | 15 | 11 | |
| Lymph node involvement | 0.0355a | |||
| Absence | 18 | 6 | 12 | |
| Presence | 29 | 17 | 12 | |
| TNM stage | 0.0415a | |||
| I–II | 26 | 9 | 17 | |
| III–IV | 21 | 14 | 7 | |
a
P<0.05. lncRNA, long non-coding RNA; MIAT, myocardial infarction associated transcript.